Dr. Gurvijay Sasan, MD

Dr. Sasan practices at Sharp Grossmont Hospital in La Mesa, California, part of Sharp HealthCare.

Dr. Sasan's NPI, 1770962847, was assigned on May 22, 2015. Dr. Sasan graduated from Ross University School of Medicine in 2015. Dr. Sasan holds California license 158730.

Dr. Sasan's primary practice is Sharp Grossmont Hospital, at 5555 Grossmont Center Drive Box 58, La Mesa, CA 91942 in San Diego County. The practice phone is (619) 465-0711.

Dr. Sasan's primary practice is Sharp Grossmont Hospital in La Mesa, California, part of Sharp HealthCare. The medical group on file is Emergency and Acute Care Medical Corporation. Dmand AI also links Dr. Sasan to 4 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sasan practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Sasan's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Sasan is board certified in critical care medicine by the American Board of Internal Medicine. Dmand AI has Dr. Sasan's licenses on file in 3 states: California, Arizona and Ohio.

Dmand AI lists chronic respiratory failure among the conditions Dr. Sasan treats.

CMS data shows 1,746 Medicare services from Dr. Sasan across 7 procedure codes in 2024, for 280 Medicare patients. Medicare paid $182,039 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 280 Medicare patients who saw Dr. Sasan in 2024. The largest group is 65 to 74, with 112 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 60% are also on Medicaid. Their average risk score is 3.01, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sasan's median patient age at 67, with 43% women.

In 2024, Dr. Sasan wrote 120 Medicare Part D claims for 42 patients. 86% of them were for generic drugs. CMS names the drug for 82 of them, across 5 drugs with 11 or more claims each, at $3,198 in total drug cost. In 2020, CMS named 131 claims across 5 drugs.

Dr. Sasan accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 68 general payments to Dr. Sasan from 21 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 99% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $572.

Dr. Sasan graduated from Ross University School of Medicine in 2015.